Clinical Trials
190 trialsiCaRe2
University of Nebraska
Recombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid Tumors
University of Southern California
BILIVER
Azienda USL Toscana Centro
ANTARES
Instituto do Cancer do Estado de São Paulo
Comparing the TDTP-RECIST With RECIST 1.1 and Other Volumetric Evaluation Methods for Assessing the Therapeutic Efficacy of Irregular Malignant Tumors
Shanghai Zhongshan Hospital
TRAP-BTC
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Pressurized Intraperitoneal Aerosolized Nab-Paclitaxel in Combination With Gemcitabine and Cisplatin for the Treatment of Biliary Tract Cancer Patients With Peritoneal Metastases
City of Hope Medical Center
TRACE-BTC
Aarhus University Hospital
Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
Cedars-Sinai Medical Center
Trifluridine/Tipiracil + Oxaliplatin in Participants With Advanced or Metastatic Biliary Tract Cancer
Case Comprehensive Cancer Center
Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types
University of Florida
EULAT
Centre Paul Strauss
PLATON
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
FAPi-2
Tata Memorial Centre
Gemcitabine and Cisplatin With or Without CPI-613 as First Line Therapy for Patients With Advanced Unresectable Biliary Tract Cancer (BilT-04)
University of Michigan Rogel Cancer Center
Target-specific immunoPET Imaging of Digestive System Carcinoma
RenJi Hospital
TRANSFORM-GBC
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
A Study of Different Dosing Schedules of Selumetinib With Cisplatin/Gemcitabine (CIS/GEM) Versus CIS/GEM Alone in Biliary Cancer
University Health Network, Toronto
A Phase IIb Randomized Clinical Trial of Immune Checkpoint Inhibitor-based Maintenance Therapy in Patients With Advanced Biliary Tract Cancer
Yonsei University
Guadecitabine and Durvalumab in Treating Patients With Advanced Liver, Pancreatic, Bile Duct, or Gallbladder Cancer
University of Southern California
DETERMINE
Cancer Research UK
Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer
City of Hope Medical Center
A Cell-free DNA Methylation Blood-Based Test for Biliary Tract Cancers Screening
Shanghai Jiao Tong University School of Medicine
STALL
Helsinki University Central Hospital
ROBOCOP
Karolinska University Hospital
Biomarker Discovery in Patients With Advanced Biliary Tract Cancer
CHA University
Artificial Intelligence-based Tumor Microenvironment Analysis for Prognosis Prediction in Gallbladder Cancer
Samsung Medical Center
Feasibility Study of Multi-Platform Profiling of Resected Biliary Tract Cancer
University of Washington
SAIB
First Affiliated Hospital of Zhejiang University
Bile Omics for Diagnosing Indeterminate Biliary Strictures
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
P-iGBC
University Hospital Plymouth NHS Trust
HPB70+
Assistance Publique - Hôpitaux de Paris
GALENT-BT
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Immunotherapy With Durva and Treme With or Without Capecitabine in Adjuvant Treatment for Biliary Tract Cancer
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
NEOGB
Rajiv Gandhi Cancer Institute & Research Center, India
RUGB
Tata Memorial Centre
ACTICCA-1
Universitätsklinikum Hamburg-Eppendorf
Camrelizumab and Chemotherapy With or Without Anlotinib as First-line Treatment for Advanced Gallbladder Cancer and Extrahepatic Cholangiocarcinoma
The First Affiliated Hospital of Zhengzhou University
PLATON
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
GECKO
University of Edinburgh
GOLD-HAIC
Tianjin Medical University Cancer Institute and Hospital
DEBATE
Asan Medical Center
Proteomic Analysis of Patients Undergoing Bariatric Surgery
Universidade Federal de Pernambuco
LIVELONG
University of California, Davis
Dasatinib for the Prevention of Oxaliplatin-Induced Neuropathy in Patients With Metastatic Gastrointestinal Cancer Receiving FOLFOX Chemotherapy With or Without Bevacizumab
Ohio State University Comprehensive Cancer Center
CaSSY
University of Pittsburgh
Toripalimab Combined With Capecitabine as Postoperative Adjuvant Therapy for Patients With Resectable Advanced Extrahepatic Biliary Tract Cancer
Tianjin Medical University Cancer Institute and Hospital
A Dual Channel Supraglottic Airway Device (LMA Gastro) for Oxygenation in Patients Undergoing ERCP
M.D. Anderson Cancer Center
TESLA RCT
Erasmus Medical Center
Target Therapy With GEMOX in Recectable Gallbladder Carcinoma Patients Monitored by ctDNA
Shanghai Jiao Tong University School of Medicine